Evidence map›Paper›PMID 38094237›Full record

ArticleFrontiers in public health2023

A prognostic model and pre-discharge predictors of post-COVID-19 syndrome after hospitalization for SARS-CoV-2 infection.

Oleksii Honchar, Tetiana Ashcheulova, Tetyana Chumachenko, Dmytro Chumachenko, Alla Bobeiko, Viktor Blazhko, Eduard Khodosh, Nataliia Matiash, Tetiana Ambrosova, Nina Herasymchuk and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Oleksii HoncharDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Tetiana AshcheulovaDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Tetyana ChumachenkoDepartment of Epidemiology, Kharkiv National Medical University, Kharkiv, Ukraine.
Dmytro ChumachenkoDepartment of Mathematical Modelling and Artificial Intelligence, National Aerospace University "Kharkiv Aviation Institute", Kharkiv, Ukraine.
Alla BobeikoDepartment of Pulmonology, MNE "Clinical City Hospital No.13" of Kharkiv City Council, Kharkiv, Ukraine.
Viktor BlazhkoDepartment of Pulmonology, MNE "Clinical City Hospital No.13" of Kharkiv City Council, Kharkiv, Ukraine.
Eduard KhodoshDepartment of Pulmonology, MNE "Clinical City Hospital No.13" of Kharkiv City Council, Kharkiv, Ukraine.
Nataliia MatiashDepartment of Pulmonology, MNE "Clinical City Hospital No.13" of Kharkiv City Council, Kharkiv, Ukraine.
Tetiana AmbrosovaDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Nina HerasymchukDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Oksana KochubieiDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Viktoriia SmyrnovaDepartment of Propedeutics of Internal Medicine No.1, Fundamentals of Bioethics and Biosafety, Kharkiv National Medical University, Kharkiv, Ukraine.
Kharkiv National Medical University · UAKharkiv State Academy of Culture · UANational Aerospace University – Kharkiv Aviation Institute · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-COVID-19 syndrome (PCS) has been increasingly recognized as an emerging problem: 50% of patients report ongoing symptoms 1 year after acute infection, with most typical manifestations (fatigue, dyspnea, psychiatric and neurological symptoms) having potentially debilitating effect. Early identification of high-risk candidates for PCS development would facilitate the optimal use of resources directed to rehabilitation of COVID-19 convalescents. Objective: To study the in-hospital clinical characteristics of COVID-19 survivors presenting with self-reported PCS at 3 months and to identify the early predictors of its development. Methods: 221 hospitalized COVID-19 patients underwent symptoms assessment, 6-min walk test, and echocardiography pre-discharge and at 1 month; presence of PCS was assessed 3 months after discharge. Unsupervised machine learning was used to build a SANN-based binary classification model of PCS development. Results: PCS at 3 months has been detected in 75% patients. Higher symptoms level in the PCS group was not associated with worse physical functional recovery or significant echocardiographic changes. Despite identification of a set of pre-discharge predictors, inclusion of parameters obtained at 1 month proved necessary to obtain a high accuracy model of PCS development, with inputs list including age, sex, in-hospital levels of CRP, eGFR and need for oxygen supplementation, and level of post-exertional symptoms at 1 month after discharge (fatigue and dyspnea in 6MWT and MRC Dyspnea score). Conclusion: Hospitalized COVID-19 survivors at 3 months were characterized by 75% prevalence of PCS, the development of which could be predicted with an 89% accuracy using the derived neural network-based classification model.

Indexed as

COVID-19Patient DischargeDyspneaFatigueHospitalizationHumansPost-Acute COVID-19 SyndromePrognosisSARS-CoV-2clinical decision rulesconvalescenceCOVID-19echocardiographyhospitalizationmachine learningpost-acute COVID-19 syndromewalk test

Identifiers

PMID38094237
PMCPMC10716462
OpenAlexW4389149663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.